The combination addresses fat loss from both directions: reduced caloric intake via appetite control and enhanced fat breakdown at the cellular level
Clinical observations report density increases of 20 to 30 percent after three to six months of consistent topical use
Aspirin-induced increase in intestinal paracellular permeability does not affect the levels of LPS in venous blood of healthy women
Bergstrom KSB, Kissoon-Singh V, Gibson DL et al (2010) Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa
Evidence strength: Very weak, mostly theoretical
But beyond weight loss, AOD 9604 offers other benefits, including: AOD 9604 was originally developed to treat obesity, but today, many people use it as a weight-loss treatment